Dr. Patrick Mills, MD

NPI: 1700844263
Total Payments
$3,374
2024 Payments
$418.40
Companies
43
Transactions
175
Medicare Patients
8,295
Medicare Billing
$482,340

Payment Breakdown by Category

Food & Beverage$3,163 (93.7%)
Education$211.29 (6.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,163 167 93.7%
Education $211.29 8 6.3%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $483.87 23 $0 (2023)
Antares Pharma, Inc. $439.99 25 $0 (2024)
Sumitomo Pharma America, Inc. $293.18 18 $0 (2024)
NeoTract Inc. $218.55 3 $0 (2019)
PFIZER INC. $192.22 11 $0 (2024)
UROVANT SCIENCES INC $191.48 10 $0 (2022)
PROGENICS PHARMACEUTICALS, INC. $139.99 7 $0 (2024)
ABBVIE INC. $129.75 8 $0 (2022)
Allergan, Inc. $105.75 1 $0 (2020)
Bayer Healthcare Pharmaceuticals Inc. $87.32 5 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $418.40 23 Sumitomo Pharma America, Inc. ($153.45)
2023 $600.86 31 Sumitomo Pharma America, Inc. ($139.73)
2022 $647.70 33 UROVANT SCIENCES INC ($131.99)
2021 $234.49 15 UROVANT SCIENCES INC ($59.49)
2020 $192.70 8 Allergan, Inc. ($105.75)
2019 $285.73 16 Antares Pharma, Inc. ($92.00)
2018 $393.48 17 NeoTract Inc. ($141.38)
2017 $600.49 32 Astellas Pharma US Inc ($365.79)

All Payment Transactions

175 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/16/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $20.58 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/19/2024 Verity Pharmaceuticals Inc. Trelstar (Drug) Food and Beverage Cash or cash equivalent $20.90 General
Category: Prostate cancer
11/17/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $23.16 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/07/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $18.16 General
Category: UROLOGY
10/10/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $18.15 General
Category: UROLOGY
09/25/2024 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $16.01 General
Category: ONCOLOGY
09/12/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $20.36 General
Category: UROLOGY
08/14/2024 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $19.44 General
Category: ONCOLOGY
08/12/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $20.02 General
Category: TESTOSTERONE REPLACEMENT THERAPY
08/06/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $20.36 General
Category: RADIOPHARMACEUTICAL
07/25/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $16.51 General
Category: UROLOGY
07/25/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $1.99 General
Category: UROLOGY
06/26/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $19.19 General
Category: TESTOSTERONE REPLACEMENT THERAPY
05/15/2024 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $22.08 General
Category: ONCOLOGY
04/30/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $17.27 General
Category: RADIOPHARMACEUTICAL
04/08/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $15.40 General
Category: HORMONE THERAPY
03/14/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $16.69 General
Category: UROLOGY
03/14/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $13.89 General
Category: HORMONE THERAPY
03/10/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $23.45 General
Category: TESTOSTERONE REPLACEMENT THERAPY
02/21/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $20.25 General
Category: RADIOPHARMACEUTICAL
02/15/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $18.06 General
Category: UROLOGY
02/13/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $22.24 General
Category: TESTOSTERONE REPLACEMENT THERAPY
01/09/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $14.24 General
Category: HORMONE THERAPY
12/14/2023 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $18.38 General
Category: Urology
11/13/2023 PROCEPT BioRobotics Corporation AQUABEAM ROBOTIC SYSTEM (Device) Food and Beverage In-kind items and services $14.91 General
Category: Urology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 23 1,992 55,379 $297,832 $105,440
2022 25 2,053 48,006 $325,097 $113,781
2021 29 2,054 51,782 $422,328 $141,402
2020 29 2,196 46,991 $387,719 $121,717
Total Patients
8,295
Total Services
202,158
Medicare Billing
$482,340
Procedure Codes
106

All Medicare Procedures & Services

106 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 216 315 $56,700 $26,619 46.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 227 340 $39,100 $19,029 48.7%
J9217 Leuprolide acetate (for depot suspension), 7.5 mg Office 2023 11 84 $56,700 $11,239 19.8%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 48 62 $27,900 $9,946 35.6%
84153 Psa (prostate specific antigen) measurement, total Office 2023 283 459 $16,065 $8,198 51.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 49 49 $10,780 $5,285 49.0%
52356 Crushing of stone of ureter with insertion of stent using an endoscope Facility 2023 13 13 $32,825 $3,654 11.1%
36415 Insertion of needle into vein for collection of blood sample Office 2023 280 494 $3,458 $3,389 98.0%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 32 66 $3,630 $2,417 66.6%
84403 Testosterone (hormone) level, total Office 2023 50 97 $5,335 $2,303 43.2%
96372 Injection of drug or substance under skin or into muscle Office 2023 28 231 $12,705 $2,198 17.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 21 22 $4,070 $2,144 52.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 29 29 $4,205 $1,849 44.0%
74018 X-ray of abdomen, 1 view Office 2023 46 71 $4,260 $1,325 31.1%
81003 Automated urinalysis test Office 2023 370 588 $4,116 $1,264 30.7%
J1071 Injection, testosterone cypionate, 1 mg Office 2023 20 52,101 $4,689 $1,144 24.4%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 17 18 $2,430 $1,117 46.0%
87086 Bacterial colony count, urine Office 2023 67 96 $1,488 $738.96 49.7%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 72 94 $4,700 $648.76 13.8%
87186 Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution Office 2023 31 42 $714.00 $344.86 48.3%
87088 Bacterial urine culture Office 2023 31 42 $1,092 $322.82 29.6%
80076 Liver function blood test panel Office 2023 17 21 $420.00 $160.20 38.1%
85014 Red blood cell concentration measurement Office 2023 34 45 $450.00 $104.40 23.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 211 331 $59,580 $27,378 46.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 219 346 $39,790 $20,454 51.4%

About Dr. Patrick Mills, MD

Dr. Patrick Mills, MD is a Urology healthcare provider based in Homewood, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700844263.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Mills, MD has received a total of $3,374 in payments from pharmaceutical and medical device companies, with $418.40 received in 2024. These payments were reported across 175 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($3,163).

As a Medicare-enrolled provider, Mills has provided services to 8,295 Medicare beneficiaries, totaling 202,158 services with total Medicare billing of $482,340. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Homewood, AL
  • Active Since 05/03/2006
  • Last Updated 05/15/2013
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1700844263

Products in Payments

  • GEMTESA (Drug) $393.88
  • XTANDI (Drug) $211.67
  • XYOSTED (Drug) $201.59
  • UroLift (Device) $197.77
  • Myrbetriq (Drug) $182.90
  • ORGOVYX (Drug) $173.62
  • NOCDURNA (Drug) $153.06
  • Xtandi (Drug) $146.14
  • PYLARIFY (Drug) $139.99
  • XIAFLEX (Biological) $85.60
  • JELMYTO (Drug) $79.63
  • Nubeqa (Drug) $76.52
  • LUPRON DEPOT (Drug) $73.80
  • GENTLECATH (Device) $66.62
  • Erleada (Drug) $54.43
  • SpeediCath (Device) $52.11
  • KEYTRUDA (Biological) $49.33
  • TLANDO (Drug) $44.52
  • OTREXUP (Drug) $43.82
  • ELIGARD (Drug) $42.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Homewood